[144] IonQ, Inc. SEC Filing

IonQ security holder plans to sell 5,000 common shares under Rule 144.

Rhea-AI Filing Summary

IonQ security holder plans to sell 5,000 common shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $242,400.00, on the NYSE. The filing notes that there are 354,279,591 common shares outstanding, providing a baseline for the company’s total share count. The 5,000 shares were acquired on 12/22/2025 by exercising stock options for cash on the same date.

The notice also lists prior Rule 10b5-1 activity, showing that 10b5-1 sales for Kathryn Chou included 20,000 common shares sold on 12/11/2025 for gross proceeds of $1,027,980.00. By signing, the seller represents that they are not aware of undisclosed material adverse information about IonQ.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IonQ (IONQ) shares are being sold in this Rule 144 notice?

The notice states that 5,000 common shares of IonQ are planned to be sold, with an aggregate market value of $242,400.00.

How were the IONQ shares in this Form 144 acquired?

The 5,000 IonQ common shares were acquired on 12/22/2025 through an exercise of stock options from the issuer, paid in cash on the same date.

What does the Form 144 filing say about IonQ shares outstanding?

The filing reports that IonQ has 354,279,591 common shares outstanding, providing context for the company’s total share count.

Were there other recent IonQ share sales related to this seller?

Yes. The filing lists 10b5-1 sales for Kathryn Chou of 20,000 common shares on 12/11/2025, with gross proceeds of $1,027,980.00 over the past three months.

Which broker is handling the planned sale of IONQ shares?

The planned sale of IonQ common shares is through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004, on the NYSE.

What representation does the seller make in this IonQ Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about IonQ’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/22/2025 - 04:28 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001935209
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IONQ,INC.
SEC File Number	001-39694
Address of Issuer	4505 Campus Drive College Park MARYLAND 20740
Phone	(301)298-7997
Name of Person for Whose Account the Securities are To Be Sold	KATHRYN CHOU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	242400.00	354279591	12/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/22/2025	Exercise of Stock Options	Issuer			5000	12/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KATHRYN CHOU 4505 Campus Drive College Park MD 20740	Common	12/11/2025	20000	1027980.00

144: Remarks and Signature

Remarks
Date of Notice	12/22/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Kathryn Chou
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)